Bleeding risk with rivaroxaban compared with vitamin K antagonists in patients aged 80 years or older with atrial fibrillation.
Hanon O, Vidal JS, Pisica-Donose G, Orvoën G, David JP, Chaussade E, Caillard L, de Jong LW, Boulloche N, Vinsonneau U, Bouée S, Krolak-Salmon P, Fauchier L, Jouanny P, Sacco G, Bellarbre F, Belmin J, Puisieux F, Lilamand M, Paillaud E, Boureau AS; SAFIR study group.
Hanon O, et al. Among authors: pisica donose g.
Heart. 2021 Sep;107(17):1376-1382. doi: 10.1136/heartjnl-2020-317923. Epub 2020 Dec 1.
Heart. 2021.
PMID: 33262185